RGNX
Regenxbio Inc
NASDAQ: RGNX · HEALTHCARE · BIOTECHNOLOGY
$8.97
+6.79% today
Updated 2026-04-30
Market cap
$452.17M
P/E ratio
—
P/S ratio
2.65x
EPS (TTM)
$-3.76
Dividend yield
—
52W range
$7 – $16
Volume
0.8M
Regenxbio Inc (RGNX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.09M | $6.12M | $7.59M | $4.59M | $10.39M | $218.50M | $35.23M | $154.57M | $470.35M | $112.72M | $90.24M | $83.33M | $170.44M |
| Revenue growth (YoY) | — | +0.5% | +24.0% | -39.5% | +126.5% | +2002.4% | -83.9% | +338.7% | +204.3% | -76.0% | -19.9% | -7.7% | +104.5% |
| Cost of revenue | $324000.00 | $1.01M | $1.50M | $959000.00 | $1.71M | $9.64M | $8.24M | $35.71M | $51.83M | $54.55M | $37.21M | $33.57M | $20.30M |
| Gross profit | $5.76M | $5.11M | $6.08M | $3.63M | $8.68M | $208.87M | $26.99M | $118.85M | $418.51M | $58.18M | $53.03M | $49.76M | $150.14M |
| Gross margin | 94.7% | 83.5% | 80.2% | 79.1% | 83.6% | 95.6% | 76.6% | 76.9% | 89.0% | 51.6% | 58.8% | 59.7% | 88.1% |
| R&D | $5.05M | $4.96M | $17.28M | $45.48M | $57.22M | $83.87M | $124.19M | $166.29M | $181.44M | $242.45M | $232.27M | $208.52M | $228.30M |
| SG&A | $5.47M | $3.85M | $11.91M | $23.59M | $27.23M | $36.85M | $51.81M | $63.82M | $79.33M | $85.28M | $88.49M | $76.62M | $82.86M |
| Operating income | $-4.78M | $-3.68M | $-23.14M | $-65.34M | $-75.89M | $88.10M | $-149.00M | $-119.23M | $159.98M | $-262.88M | $-268.13M | $-233.35M | $-161.20M |
| Operating margin | -78.5% | -60.2% | -304.9% | -1423.8% | -730.2% | 40.3% | -422.9% | -77.1% | 34.0% | -233.2% | -297.1% | -280.0% | -94.6% |
| EBITDA | $-4.78M | $-3.65M | $-22.71M | $-64.80M | $-73.20M | $92.08M | $-90.34M | $-96.83M | $169.54M | $-244.24M | $-239.46M | $-198.23M | $-145.58M |
| EBITDA margin | -78.5% | -59.7% | -299.3% | -1412.0% | -704.3% | 42.1% | -256.4% | -62.6% | 36.0% | -216.7% | -265.4% | -237.9% | -85.4% |
| EBIT | $-4.79M | $-3.68M | $-22.79M | $-65.34M | $-75.89M | $88.10M | $-97.49M | $-105.24M | $159.98M | $-257.15M | $-256.78M | $-214.44M | $-161.20M |
| Interest expense | $611000.00 | $321000.00 | $20000.00 | $0.00 | $0.00 | $0.00 | $107.22M | $771000.00 | $26.28M | $23.25M | $6.86M | $12.66M | $45.01M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5.39M | $-4.00M | $-22.81M | $-62.97M | $-73.17M | $99.94M | $-94.73M | $-111.25M | $127.84M | $-280.32M | $-263.49M | $-227.10M | $-193.88M |
| Net income growth (YoY) | — | +25.7% | -469.8% | -176.0% | -16.2% | +236.6% | -194.8% | -17.4% | +214.9% | -319.3% | +6.0% | +13.8% | +14.6% |
| Profit margin | -88.5% | -65.4% | -300.6% | -1372.1% | -704.0% | 45.7% | -268.9% | -72.0% | 27.2% | -248.7% | -292.0% | -272.5% | -113.8% |